Pivotal debuts with $301M life sciences fund

Pivotal bioVenture Partners launched with a $301 million fund to invest in early stage therapeutics companies.

Managing partners Tracy Saxton and Vincent Cheung co-founded the firm. Saxton previously held investment roles at Roche Venture Fund and SV Life Sciences. Cheung is COO of Hong Kong-based Nan Fung Group, the sole LP in Pivotal's fund...